Table 3.
Demographic data (means ± SD)
| Baseline Exercise (n = 16) | Baseline Control (n = 16) | Baseline Total (n = 32) | |
|---|---|---|---|
| Age (years) | 69.6 ± 11.4 | 63.6 ± 12.2 | 66.5 ± 12 |
| Body weight (kg) | 64.7 ± 10.2 | 72.2 ± 14.2 | 68.4 ± 12.7 |
| Body mass index (kg/m2) | 24.8 ± 3.1 | 26.6 ± 4.6 | 25.7 ± 4 |
| Stature (cm) | 161.5 ± 9 | 164.5 ± 6.1 | 163 ± 7.7 |
| Disease duration (years) | 8 ± 2 | 8 ± 2 | 8 ± 2 |
| History of DUs (%) | 30 ± 3 | 29 ± 5 | 30 ± 4 |
| Clinical course of DUs* | 1.2 ± 0.92 | 1.3 ± 0.81 | 1.2 ± 0.86 |
| Raynaud’s treatment | 9/16 | 13/16 | 22/32 |
| Nifedipine | 7/9 | 7/13 | 14/32 |
| Sildenafil | 2/9 | 6/13 | 8/32 |
| Blood pressure treatment | 8/16 | 7/16 | 15/32 |
| Candesartan | 3/8 | 3/7 | 6/32 |
| Ramipril | 5/8 | 4/7 | 9/32 |
*Mean number of DUs per patient per year during the last 5 years (2012–2017)